| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,111 |
981 |
$375.18 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
96 |
95 |
$349.14 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
96 |
95 |
$348.02 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,029 |
1,784 |
$97.08 |
| 80061 |
Lipid panel |
1,608 |
1,599 |
$0.00 |
| 3077F |
|
185 |
166 |
$0.00 |
| 82540 |
|
511 |
507 |
$0.00 |
| 86703 |
|
441 |
437 |
$0.00 |
| 82274 |
|
203 |
203 |
$0.00 |
| 99442 |
|
183 |
182 |
$0.00 |
| 3078F |
|
636 |
564 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
28 |
27 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
107 |
87 |
$0.00 |
| 84460 |
|
13 |
13 |
$0.00 |
| 99201 |
|
16 |
13 |
$0.00 |
| 84439 |
|
25 |
25 |
$0.00 |
| 84450 |
|
13 |
13 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30 |
29 |
$0.00 |
| 90653 |
|
12 |
12 |
$0.00 |
| 83540 |
|
12 |
12 |
$0.00 |
| 82947 |
|
12 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,788 |
3,449 |
$0.00 |
| 90686 |
|
27 |
27 |
$0.00 |
| 1111F |
|
156 |
135 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
582 |
577 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
337 |
313 |
$0.00 |
| 85027 |
|
633 |
627 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,109 |
2,092 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
1,748 |
1,656 |
$0.00 |
| 3075F |
|
188 |
178 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
329 |
321 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
932 |
857 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
562 |
559 |
$0.00 |
| 82043 |
|
511 |
507 |
$0.00 |
| 99443 |
|
102 |
97 |
$0.00 |
| 3074F |
|
499 |
448 |
$0.00 |
| 86780 |
|
40 |
40 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
510 |
497 |
$0.00 |
| 3079F |
|
160 |
150 |
$0.00 |
| 4450F |
|
33 |
31 |
$0.00 |
| 1220F |
|
41 |
41 |
$0.00 |
| 3044F |
|
245 |
242 |
$0.00 |
| 86592 |
|
28 |
28 |
$0.00 |
| 81001 |
|
26 |
24 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
17 |
17 |
$0.00 |
| 82607 |
|
13 |
13 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
59 |
58 |
$0.00 |
| 83550 |
|
12 |
12 |
$0.00 |
| 86593 |
|
13 |
12 |
$0.00 |
| 82728 |
|
12 |
12 |
$0.00 |
| 90656 |
|
33 |
33 |
$0.00 |